Archives
Meta-analysis of randomized controlled trials: Drug treatment for panic disorder with or without agoraphobia.
20 Jan, 2022 | 09:06h | UTC
Study shows that the retinal age gap might be a potential biomarker of aging linked to increased mortality risk.
20 Jan, 2022 | 09:04h | UTCRetinal age gap as a predictive biomarker for mortality risk – British Journal of Ophthalmology (link to abstract – $ for full-text)
News Release: Difference between retina’s biological age and person’s real age linked to heightened death risk – BMJ
Commentary on Twitter
Difference between retina’s biological age and person’s real age linked to heightened death risk finds @BMJ_Ophth study https://t.co/TNveo5E77D
— BMJ Group (@bmj_company) January 19, 2022
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update.
20 Jan, 2022 | 08:57h | UTC
Commentary on Twitter
Out on @JCO_ASCO the new ASCO/OH guidelines for adjuvant bisphosphonates in BC
Important to weight risks and benefits based on the risk profile of the disease, financial toxicity, drug availability, patient preferences, comorbidities & life expectancy. https://t.co/6noyYplALB
— Paolo Tarantino (@PTarantinoMD) January 18, 2022
Systematic Review: Prevalence, incidence and survival of heart failure.
20 Jan, 2022 | 09:00h | UTCPrevalence, incidence and survival of heart failure: a systematic review – Heart
O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee.
20 Jan, 2022 | 08:59h | UTC
Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis.
20 Jan, 2022 | 08:52h | UTC
Review: Evaluating the patient with a pulmonary nodule.
20 Jan, 2022 | 08:56h | UTCEvaluating the Patient With a Pulmonary Nodule: A Review – JAMA (free for a limited period)
Author Interview: Evaluation and Management of Patients With Pulmonary Nodules
Consensus Statement: Exercise/physical activity in individuals with Type 2 Diabetes.
20 Jan, 2022 | 08:51h | UTC
Commentary from the author on Twitter
Exercise/Physical Activity in Individuals with
Type 2 Diabetes: A Consensus Statement from
the American College of Sports Medicine
Honored to contribute w/several esteemed colleagues to this report now out on #exercise & #diabetes @MSSEonline @ACSMNews https://t.co/UNmoU2BgLR— Juleen R. Zierath (@JuleenRZierath) January 14, 2022
Review: Diagnosis and treatment of polycystic ovary syndrome.
20 Jan, 2022 | 08:54h | UTCDiagnosis and Treatment of Polycystic Ovary Syndrome – JAMA (free for a limited period)
How do we make decisions for the most immature babies, with their families?
20 Jan, 2022 | 08:49h | UTCHow do we make decisions for the most immature babies, with their families? – Neonatal Research
Cumulative 5-year results of a randomized controlled trial comparing biological Mesh with primary perineal wound closure after extralevator abdominoperineal resection.
20 Jan, 2022 | 08:40h | UTCCumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study) – Annals of Surgery (link to abstract – $ for full-text)
Consensus statement on hemostatic management, anticoagulation, and antiplatelet therapy in liver transplantation.
20 Jan, 2022 | 08:47h | UTC
Expert consensus for plasma and platelet transfusion practice in critically ill children.
20 Jan, 2022 | 08:44h | UTC
Review: Cannabis-based medicines and medical cannabis for chronic neuropathic pain.
20 Jan, 2022 | 08:39h | UTCCannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain – CNS Drugs
Related:
Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain.
Cannabis products are being sold as sleep remedies – here’s the evidence about their effectiveness.
Guideline: Medical cannabis or cannabinoids for chronic pain.
NICE Guideline: Cannabis-Based Medicinal Products
Short Review: Drug Interactions with Cannabinoids
Meta-Analysis: Cannabinoids Not Effective for Cancer-Related Pain
Systematic Review: School closures during social lockdown and mental health, health behaviors, and well-being among children and adolescents during the first Covid-19 wave.
19 Jan, 2022 | 09:00h | UTCEditorial: Pandemic Recovery for Children—Beyond Reopening Schools – JAMA Pediatrics
Commentary: More Behavioral Issues Reported in Children When School Is Virtual – Psychiatric News Alert
Related:
M-A: Child and youth mental health problems have doubled during COVID-19.
Adolescents’ recreational screen time doubled during pandemic, affecting mental health.
More data on the harmful effects of the COVID-19 pandemic on the mental health of adolescents.
COVID has caused ‘mass trauma,’ worsening mental health globally.
COVID’s mental-health toll: how scientists are tracking a surge in depression
WHO: COVID-19 disrupting mental health services in most countries
Commentary on Twitter (thread – click for more)
https://twitter.com/benryanwriter/status/1483482171000111111
M-A: Association of Sodium-Glucose Cotransporter 2 Inhibitors with cardiovascular outcomes in patients with Type 2 Diabetes and other risk factors for cardiovascular disease.
20 Jan, 2022 | 08:42h | UTC
Commentary on Twitter
This meta-analysis found that use of SGLT2-Is was associated with lower occurrence of cardiovascular death or hospitalization for heart failure by 33% in high-risk patients. @mukul_bhattarai @AkcharAl @AbhiKulk82 @mominsiddique01 @Mohsin_Salih19 https://t.co/omPP6Qwofg
— JAMA Network Open (@JAMANetworkOpen) January 5, 2022
COVID-19 testing infographics.
19 Jan, 2022 | 08:59h | UTCCOVID-19 testing infographics – British Society for Immunology
Commentary on Twitter
It’s important to understand #COVID19 testing so everyone can make informed decisions about their health ℹ🦠
Our infographics & blog have been updated with the latest information & guidance so you can find out what different tests mean for you 👉https://t.co/7a5Ul6tEZn pic.twitter.com/mUzdZc13aa
— British Society for Immunology (@britsocimm) January 17, 2022
Placebo effect accounts for more than two-thirds of COVID-19 vaccine adverse events, researchers find.
19 Jan, 2022 | 08:53h | UTCOriginal Study: Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis – JAMA Network Open
Commentary: ‘Nocebo effect’: two-thirds of Covid jab reactions not caused by vaccine, study suggests – The Guardian
The pandemic’s true death toll: millions more than official counts.
19 Jan, 2022 | 08:57h | UTCThe pandemic’s true death toll: millions more than official counts – Nature
Related:
Global Covid-19 deaths surpass five million.
Under-reporting of deaths limits our understanding of true burden of covid-19.
Study shows COVID-19 has caused the biggest decrease in life expectancy since World War II.
Just how do deaths due to COVID-19 stack up?
Exploring the gap between excess mortality and COVID-19 deaths in 67 countries.
COVID-19 has caused 6.9 million deaths globally, more than double what official reports show
Commentary on Twitter
The official global death toll for the COVID-19 pandemic has reached 5.5 million, but that figure is a significant underestimate. @Nature reports how researchers are striving to narrow the uncertainties for a global estimate of pandemic deaths. https://t.co/061s4SJrRD
— Nature Portfolio (@NaturePortfolio) January 18, 2022
RCT: In non–critically ill hospitalized patients with COVID-19, the use of a P2Y12 Inhibitor (ticagrelor in 63% of patients and clopidogrel in 37%) in addition to a therapeutic dose of heparin did not improve survival free of organ support compared to therapeutic heparin alone.
19 Jan, 2022 | 08:56h | UTCEditorial: Antiplatelet Therapy in Patients With COVID-19—More Is Less? – JAMA
Commentary: Adding a P2Y12 Inhibitor Does Not Improve Outcomes in COVID-19 – HealthDay
Opinion: The COVID-Risk social contract is under negotiation.
19 Jan, 2022 | 08:48h | UTCThe COVID-Risk Social Contract Is Under Negotiation – The Atlantic (a few articles per month are free)
Disruptions in maternal health service use during the COVID-19 pandemic in 2020: experiences from 37 health facilities in low-income and middle-income countries.
19 Jan, 2022 | 08:50h | UTC
Commentary from one of the authors on Twitter (thread – click for more)
Just out: **Effect of COVID-19 pandemic on maternal health services at 37 facilities in six countries** 1/
Have learned and been inspired by this collaboration including: @PIH @GHResearchCore @HMSghsm @jcmugunga @isabelfulcher @megan_b_murray https://t.co/nKIRhJS2Jm pic.twitter.com/uOkyuNRA1w
— Bethany Hedt-Gauthier, PhD (@BHedtGauthier) January 10, 2022
WHO says there’s no evidence healthy children and adolescents need Covid boosters.
19 Jan, 2022 | 08:46h | UTCWHO says there’s no evidence healthy children and adolescents need Covid boosters – CNBC
Opinion: The world won’t be able to boost its way out of the coronavirus pandemic.
19 Jan, 2022 | 08:47h | UTCThe world won’t be able to boost its way out of the coronavirus pandemic – Politico
RCT: In critically ill adults, using a balanced multielectrolyte solution did not lower the risk of death or acute kidney injury compared to standard saline.
19 Jan, 2022 | 08:41h | UTCBalanced Multielectrolyte Solution versus Saline in Critically Ill Adults – New England Journal of Medicine (link to abstract – $ for full-text)
Related:
Commentary on Twitter
https://twitter.com/NEJM/status/1483540959518281730